NYU Core Grant for Cardiovascular Faculty Recruitment

描述（由申请人提供）：心血管疾病是发病率和死亡率的主要原因，在我国每年造成900，000多人死亡，在全世界造成数百万人死亡。纽约大学医学院已将改善心血管健康确定为未来十年的关键战略重点之一。为此，医学院正在投资于教师，设施和基础设施的增强，以支持在心血管研究，教育和患者护理的世界级计划的持续增长。作为NIH NHLBI ARRA/P30机制的一部分，本申请要求支持启动包，以聘请一名新的独立研究者，他将加入我们的心脏病学部门（核心中心）和心血管研究中心。经过全国性的搜索，我们已经确定了一个非常有前途的新的独立研究者准备通过基础和转化研究在一个非常相关的NHLBI -血管生物学和疾病领域的心血管健康作出重要贡献。新的研究员将获得医学和细胞生物学系的终身教职，并加入我们的Sackler生物科学研究生课程。他将加入心脏病科和更广泛的纽约大学社区内充满活力的研究环境，拥有从基础实验室研究到以患者为导向的临床研究的专业知识。他将获得一个慷慨的启动包，旨在确保他作为一个新的独立调查员取得成功，并支持他发展成为一个富有成效的既定调查员，包括工资，方案和试点项目支持，为期不少于四年。最后，新独立的调查员将受益于高度互动和培养的环境，由具有成功职业发展和协作良好记录的高级调查员提供正式指导。这位新研究员的招聘肯定会“有助于建立一个多学科研究人员的社区，重点是与NHLBI的使命相关的生物医学研究领域”。

DESCRIPTION (provided by applicant): Cardiovascular disease is a leading cause of morbidity and mortality, accounting for upwards of 900,000 deaths annually in our country and many millions more worldwide. NYU School of Medicine has identified improved cardiovascular health as one of its key strategic priorities for the next decade. Toward that end, the School of Medicine is Investing in faculty, facilities and infrastructure enhancements to support the continued growth of a world-class program in cardiovascular research, education, and patient care. As part of the NIH NHLBI ARRA/P30 mechanism, this application requests support for a start-up package to hire a Newly-Independent Investigator who will join our Division of Cardiology (Core Center) and the Cardiovascular Research Center. Following a national search, we have identified an extraordinarily promising newly-independent investigator poised to make Important contributions to cardiovascular health through fundamental and translational research in an area of great relevance to the NHLBI - vascular biology and disease. The new investigator will receive a tenure-track appointment in the Departments of Medicine and Cell Biology, and join our Sackler Graduate Program in Biological Sciences. He will join a vibrant research environment within the Division of Cardiology and the broader NYU community, with expertise that ranges from fundamental laboratory-based studies to patient-oriented clinical research. He will be provided with a generous start-up package designed to assure his success as a newly-independent investigator and support his evolution into a productive established investigator, including salary, programmatic and pilot project support for a period of no less than four years. Finally, the newly-independent investigator will benefit from a highly interactive and nurturing environment, with formal mentoring provided by senior investigators with a strong track-record of successful career development and collaboration. The recruitment of this new investigator will most certainly "contribute to the building of a community of multidisciplinary researchers focusing on areas of biomedical research that are relevant" to the mission of the NHLBI.